News-Papers
Testimonial
Video Gallery
Powered by Phoca Gallery
Search
Follow us...
Latest
- Impact of fish oil and melatonin on cachexia in patients with advanced gastrointestinal cancer: a randomized pilot study
- Somatostatin receptor gene expression in neuroblastoma
- Retinoic acid and interferon alpha act synergistically as antiangiogenic and antitumor agents against human head and neck squamous cell carcinoma
- Melatonin, pineal gland and sleep disorders: from theory to practice
- Immunological modulation by 1α,25-dihydroxyvitamin D3 in patients with squamous cell carcinoma of the head and neck
- Plasma prolactin responses to thyrotropin-releasing hormone in patients with breast cancer
- Peptide receptor radionuclide therapy (PRRT) with 177Lu-DOTATATE in individuals with neck or mediastinal paraganglioma (PGL)
- Randomized, double-blind clinical trial, controlled with placebo, of the toxicology of chronic melatonin treatment
- Prolactin secreting renal cell carcinoma
- Phase I study of the somatostatin analogue somatuline in refractory small-cell lung carcinoma
- Perioperative bromocriptine adjuvant treatment for operable breast cancer
- Serum prolactin after chest wall surgery: elevated levels after mastectomy
- Current status of retinoids in chemoprevention of oral squamous cell carcinoma: an overview
- Inhibitory effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 on the growth of the androgen-independent Dunning R-3327-AT-1 rat prostate cancer
- Growth hormone-releasing hormone antagonists reduce prostatic enlargement and inflammation in carrageenan-induced chronic prostatitis
- Effects of octreotide therapy in progressive head and neck paragangliomas: case series
- Salivary Levels Vitamin E and C in Different Histological Grading of Oral Cancer
- Rationale and Plan for Vitamin D Food Fortification: A Review and Guidance Paper
Most Read
- All-trans-retinoic acid and cancer
- The Di Bella Method (DBM)
- Biography
- About melatonin - 1996
- The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
- Bibliography
- Somatostatin in oncology, the overlooked evidences
- Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
- Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
- Vademecum
- Frequently Asked Questions
- How effective is chemo therapy?
- Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
- Declaration recommends eliminate the use of Impact factor for research evaluation
- Complete objective response to biological therapy of plurifocal breast carcinoma
- Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
- Malignant pleural mesothelioma, stage T3-T4 - Consideration of a case study
- Novel synergistic mechanism for sst2 somatostatin and TNFalpha receptors to induce apoptosis: crosstalk between NF-kappaB and JNK pathways